Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Nicole Gifford

ID: 1b83c151-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

RFEM’s Biosimilars Inter Partes Review (IPR) Dashboard

Biosimilars Law Bulletin · November 14, 2018

AbbVie Files BPCIA Suit Against Boehringer Ingelheim Over Humira® (Adalimumab)

Biosimilars Law Bulletin · August 15, 2017

Two New Applications for Trastuzumab (Herceptin®) Biosimilars Pending at FDA

Biosimilars Law Bulletin · August 11, 2017

Sandoz Enters IPR Battlefield on Humira® Patents

Biosimilars Law Bulletin · August 10, 2017

Samsung Bioepis and Merck Launch Renflexis® in the U.S.

Biosimilars Law Bulletin · August 9, 2017

Previous

12...11

Next

Practice Areas

Health Care and Life Sciences

Jurisdictions

Washington, D.C.

Publishing Record

Publisher Since 2017

Total Articles 51

Most Recent November 14, 2018

Cite This Author

Nicole Gifford, Rothwell Figg

LexBlog Author ID:

1b83c151-2619-30fb-68c4

www.lexblog.com/author/ngifford

Contact

FirmRothwell Figg

Emailngifford@rothwellfigg.com

BlogBiosimilars Law Bulletin

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog